BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24845028)

  • 1. Targeting signal transducer and activator of transcription 3 contributes to the solamargine-inhibited growth and -induced apoptosis of human lung cancer cells.
    Zhou Y; Tang Q; Zhao S; Zhang F; Li L; Wu W; Wang Z; Hann S
    Tumour Biol; 2014 Aug; 35(8):8169-78. PubMed ID: 24845028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1.
    Tang Q; Zheng F; Wu J; Xiao Q; Li L; Hann SS
    Cell Physiol Biochem; 2017; 43(6):2310-2326. PubMed ID: 29073599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells.
    Chen Y; Tang Q; Xiao Q; Yang L; Hann SS
    J Cell Mol Med; 2017 Feb; 21(2):222-233. PubMed ID: 27620163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
    Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S
    J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of ERK and Mutual Regulation of Stat3 and SP1 Contribute to Inhibition of PDK1 Expression by Atractylenolide-1 in Human Lung Cancer Cells.
    Xiao Q; Zheng F; Wu J; Tang Q; Wang W; Hann SS
    Cell Physiol Biochem; 2017; 43(6):2353-2366. PubMed ID: 29073620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis in human hepatoma SMMC-7721 cells by solamargine from Solanum nigrum L.
    Ding X; Zhu FS; Li M; Gao SG
    J Ethnopharmacol; 2012 Jan; 139(2):599-604. PubMed ID: 22172325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells.
    Liang CH; Shiu LY; Chang LC; Sheu HM; Kuo KW
    Mol Nutr Food Res; 2007 Aug; 51(8):999-1005. PubMed ID: 17639997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new xanthatin analogue 1β-hydroxyl-5α-chloro-8-epi-xanthatin induces apoptosis through ROS-mediated ERK/p38 MAPK activation and JAK2/STAT3 inhibition in human hepatocellular carcinoma.
    Fang XY; Zhang H; Zhao L; Tan S; Ren QC; Wang L; Shen XF
    Biochimie; 2018 Sep; 152():43-52. PubMed ID: 29960031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 10-HDA Induces ROS-Mediated Apoptosis in A549 Human Lung Cancer Cells by Regulating the MAPK, STAT3, NF-
    Lin XM; Liu SB; Luo YH; Xu WT; Zhang Y; Zhang T; Xue H; Zuo WB; Li YN; Lu BX; Jin CH
    Biomed Res Int; 2020; 2020():3042636. PubMed ID: 33376719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells.
    Chang KT; Tsai CM; Chiou YC; Chiu CH; Jeng KS; Huang CY
    Am J Physiol Lung Cell Mol Physiol; 2005 Sep; 289(3):L446-53. PubMed ID: 15894558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of PI3-K/Akt and reduction of SP1 and p65 expression increase the effect of solamargine on suppressing EP4 expression in human lung cancer cells.
    Chen Y; Tang Q; Wu J; Zheng F; Yang L; Hann SS
    J Exp Clin Cancer Res; 2015 Dec; 34():154. PubMed ID: 26689593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fe3O4-solamargine induces apoptosis and inhibits metastasis of pancreatic cancer cells.
    Xie X; Zhang X; Chen J; Tang X; Wang M; Zhang L; Guo Z; Shen W
    Int J Oncol; 2019 Mar; 54(3):905-915. PubMed ID: 30483763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solamargine enhances HER2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin.
    Liang CH; Shiu LY; Chang LC; Sheu HM; Tsai EM; Kuo KW
    Chem Res Toxicol; 2008 Feb; 21(2):393-9. PubMed ID: 18078328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel reciprocal interaction of lncRNA HOTAIR and miR-214-3p contribute to the solamargine-inhibited PDPK1 gene expression in human lung cancer.
    Tang Q; Zheng F; Liu Z; Wu J; Chai X; He C; Li L; Hann SS
    J Cell Mol Med; 2019 Nov; 23(11):7749-7761. PubMed ID: 31475459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential treatment of HPV E6 and E7-expressing TC-1 cells with bortezomib and celecoxib promotes apoptosis through p-p38 MAPK-mediated downregulation of cyclin D1 and CDK2.
    Kim JE; Lee JI; Jin DH; Lee WJ; Park GB; Kim S; Kim YS; Wu TC; Hur DY; Kim D
    Oncol Rep; 2014 May; 31(5):2429-37. PubMed ID: 24627094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LukS-PV induces cell cycle arrest and apoptosis through p38/ERK MAPK signaling pathway in NSCLC cells.
    Qiang Y; Ma F; Wang Z; Nie Z; Xu L; Ding P; Ma X
    Biochem Biophys Res Commun; 2020 Jan; 521(4):846-852. PubMed ID: 31708104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer.
    Wang CY; Chao TT; Tai WT; Chang FY; Su WP; Chen YL; Chen PT; Weng CY; Yuan A; Shiau CW; Yu CJ; Chen KF
    J Thorac Oncol; 2014 Apr; 9(4):488-96. PubMed ID: 24736071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymecycline reverses acquired EGFR-TKI resistance in non-small-cell lung cancer by targeting GRB2.
    Chen Y; Wu J; Yan H; Cheng Y; Wang Y; Yang Y; Deng M; Che X; Hou K; Qu X; Zou D; Liu Y; Zhang Y; Hu X
    Pharmacol Res; 2020 Sep; 159():105007. PubMed ID: 32561477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.